Tag - liquid biopsy

From Experimentation to Execution: How 2025 Reset the Trajectory of Healthcare and What 2026 Will Demand

Abbott to acquire Exact Sciences

2023 Watch List: Top 10 Precision Medicine Technologies and Issues

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

Time Is What We Want Most – Why Wasting Any More of It?

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide

Foundation Medicine and InformedDNA® Collaborate to Improve Access to Genetic Counseling for Advanced Cancer Patients

Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

Micronoma Raises $3.5 Million in Convertible Note Financing

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

2020 Was Not Just About COVID-19

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

Copyright © 2026. enlighenbio LLC. All rights reserved.